Growth Metrics

Insmed (INSM) Amortization of Deferred Charges (2016 - 2026)

Insmed's Amortization of Deferred Charges history spans 15 years, with the latest figure at $1.4 million for Q1 2026.

  • Quarterly Amortization of Deferred Charges fell 24.15% to $1.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Mar 2026, down 74.36% year-over-year, with the annual reading at $524000.0 for FY2025, 97.28% down from the prior year.
  • Amortization of Deferred Charges came in at $1.4 million for Q1 2026, up from $524000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $14.1 million in Q4 2024 to a low of -$9.9 million in Q4 2023.
  • The 5-year median for Amortization of Deferred Charges is $1.7 million (2025), against an average of $1.7 million.
  • Year-over-year, Amortization of Deferred Charges tumbled 347.61% in 2023 and then surged 242.65% in 2024.
  • Insmed's Amortization of Deferred Charges stood at $4.0 million in 2022, then crashed by 347.61% to -$9.9 million in 2023, then soared by 242.65% to $14.1 million in 2024, then plummeted by 96.28% to $524000.0 in 2025, then surged by 163.74% to $1.4 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Amortization of Deferred Charges are $1.4 million (Q1 2026), $524000.0 (Q4 2025), and $1.3 million (Q3 2025).